About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Il6sttm1Thir
targeted mutation 1, Toshio Hirano
MGI:2386991
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Il6sttm1Thir/Il6sttm1Thir B6.Cg-Il6sttm1Thir MGI:3843778
hm2
Il6sttm1Thir/Il6sttm1Thir involves: 129 * C57BL/6 MGI:3843817
hm3
Il6sttm1Thir/Il6sttm1Thir Not Specified MGI:3843660
cx4
Il6sttm1Thir/Il6sttm1Thir
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
involves: 129 * C57BL/6 * DBA MGI:3843819
cx5
Il6sttm1Thir/Il6sttm1Thir
Rag2tm1Fwa/Rag2tm1Fwa
involves: 129S/SvEv * C57BL/6 MGI:3843820


Genotype
MGI:3843778
hm1
Allelic
Composition
Il6sttm1Thir/Il6sttm1Thir
Genetic
Background
B6.Cg-Il6sttm1Thir
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6sttm1Thir mutation (1 available); any Il6st mutation (80 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• osteoblasts reduce their proliferation and their alkaline phosphatase activity by a greater amount than controls when cultured with IL-6 family cytokines
• proliferation reduction caused by IL-6/sIL-6R, IL-11, and LIF were 43%, 36%, and 13% compared to 32%, 20%, and 10% in controls
• osteoblast activity is increased 2.8- and 2.0- fold compared to controls when cultured with IL-6/sIL-6R or IL-11
• skeleton area is 5% higher than in controls
• bone mineral content is 16% higher than in controls
• bone mineral density is 11% greater in these mice than in controls
• trabecular number and total bone volume of the tibia is increased by a third
• trabecular thickness is also increased and trabecular separation is decreased
• mineral apposition rate is augmented in these mice
• bone formation rate is augmented in these mice

cellular
• osteoblasts reduce their proliferation and their alkaline phosphatase activity by a greater amount than controls when cultured with IL-6 family cytokines
• proliferation reduction caused by IL-6/sIL-6R, IL-11, and LIF were 43%, 36%, and 13% compared to 32%, 20%, and 10% in controls
• osteoblast activity is increased 2.8- and 2.0- fold compared to controls when cultured with IL-6/sIL-6R or IL-11




Genotype
MGI:3843817
hm2
Allelic
Composition
Il6sttm1Thir/Il6sttm1Thir
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6sttm1Thir mutation (1 available); any Il6st mutation (80 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• mice develop RA starting at 8 months of age
• incidence is about 45% between 11 and 15 months of age, and 100% in mice over 16 months of age
• RA includes swelling and redness of the paws and limited mobility of the ankle or wrist joints
• joints have severe synovitis with destructive changes including marked proliferation of the synovium, infiltration of inflammatory cells, fibrin deposits and severe bone destruction
• the elbows and knees are affected symmetrically in many diseased mice and become rigid
• severity scores are significantly higher in female mice than males (13.5 in year-old females versus 9.6 in year-old males)
• osteoporosis is noted around inflamed joints of older mice

immune system
• injection with the T cell superantigen SEB does not cause clonal deletion of T-cells bearing Vbeta8 TCR chains as it does in wild-type mice
• inhibition of activation induced cell death by IL-6 is almost three times greater than in wild-type T cells
• in older mice with arthritis, the frequency of double-negative thymocytes is increased by 40 fold
• this population included B cells, plasma cells and dendritic cells
• in older mice with arthritis, the frequency of double-positive thymocytes is reduced by 40 fold
• decreases in this population are observed starting at 18 weeks of age before arthritis as set in
• increased numbers of neutrophils are found in the lymph nodes of mice with arthritis
• almost all CD4+ T cells bear activation or memory markers
• there is a three-fold increase in single-positive thymocytes of older mice with arthritis
• increases in this population are observed starting at 18 weeks of age before arthritis as set in
• IgA levels are slightly elevated in mice one year of age
• IgG1 levels are slightly elevated in mice one year of age
• IgG2a levels are slightly elevated in female mice one year of age
• IgG2b levels are slightly elevated in male mice one year of age
• T cells from lymph nodes of non-arthritic mice have higher rates of proliferation in response to anti-CD3 treatment than controls
• thymocytes from 12 week old mice hyper-proliferate in response to anti-CD3 treatment
• 1 year old mice have elevated levels of rheumatoid factor (Ig class)
• 1 year old mice have elevated levels of anti-ribonuclear protein antibodies with higher levels found in females
• 1 year old mice have elevated levels of anti-dsDNA antibodies with higher levels found in females
• 1 year old mice have elevated levels of anti-ssDNA antibodies with higher levels found in females
• mice develop RA starting at 8 months of age
• incidence is about 45% between 11 and 15 months of age, and 100% in mice over 16 months of age
• RA includes swelling and redness of the paws and limited mobility of the ankle or wrist joints
• joints have severe synovitis with destructive changes including marked proliferation of the synovium, infiltration of inflammatory cells, fibrin deposits and severe bone destruction
• the elbows and knees are affected symmetrically in many diseased mice and become rigid
• severity scores are significantly higher in female mice than males (13.5 in year-old females versus 9.6 in year-old males)

hematopoietic system
• injection with the T cell superantigen SEB does not cause clonal deletion of T-cells bearing Vbeta8 TCR chains as it does in wild-type mice
• inhibition of activation induced cell death by IL-6 is almost three times greater than in wild-type T cells
• in older mice with arthritis, the frequency of double-negative thymocytes is increased by 40 fold
• this population included B cells, plasma cells and dendritic cells
• in older mice with arthritis, the frequency of double-positive thymocytes is reduced by 40 fold
• decreases in this population are observed starting at 18 weeks of age before arthritis as set in
• increased numbers of neutrophils are found in the lymph nodes of mice with arthritis
• almost all CD4+ T cells bear activation or memory markers
• there is a three-fold increase in single-positive thymocytes of older mice with arthritis
• increases in this population are observed starting at 18 weeks of age before arthritis as set in
• IgA levels are slightly elevated in mice one year of age
• IgG1 levels are slightly elevated in mice one year of age
• IgG2a levels are slightly elevated in female mice one year of age
• IgG2b levels are slightly elevated in male mice one year of age
• T cells from lymph nodes of non-arthritic mice have higher rates of proliferation in response to anti-CD3 treatment than controls
• thymocytes from 12 week old mice hyper-proliferate in response to anti-CD3 treatment

endocrine/exocrine glands
• thymocytes from 12 week old mice hyper-proliferate in response to anti-CD3 treatment

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
rheumatoid arthritis DOID:7148 OMIM:180300
J:133059




Genotype
MGI:3843660
hm3
Allelic
Composition
Il6sttm1Thir/Il6sttm1Thir
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6sttm1Thir mutation (1 available); any Il6st mutation (80 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• there is almost a 3-fold increase in the number of cells contained in the peritoneal exudate of 5-month old mice
• size of spleen increases with age with mean cellularity being over 2-fold higher than controls by 5 months of age

immune system
• size of spleen increases with age with mean cellularity being over 2-fold higher than controls by 5 months of age
• the number of CD45R+ B cells is increased in in the enlarged lymph node organs
• the number of CD4-positive T cells increases by 1.3 to 2.7 fold in in the enlarged lymph node organs
• the number of CD8-positive T cells increases by 1.3 to 2.7 fold in the enlarged lymph node organs
• B cells stimulated with anti-CD40 produce more immunoglobulins than controls
• addition of IL-6 to stimulation enhances even more the production of immunoglobulins
• production of antigen-specific IgG2a is increased in these mice after immunization with T cell dependent antigen
• production of antigen-specific IgG2b is increased in these mice after immunization with T cell dependent antigen
• by 5 months of age
• by 5 months of age, enlargement occurs to cervical, axillar, inguinal, and mesenteric lymph nodes
• by 5 months of age
• by 5 months of age
• by 5 months of age
• bone marrow derived dendritic cells treated with IL-6 have a greater reduction in MHC-II surface expression than in controls
• dendritic cells isolated from lymph nodes have a 40% reduction in surface expression of MHC-II
• activated T cells secrete 1.6-fold more IFN-gamma than controls
• CD4+ T cells produce less 0.6 fold-less IL-4 than controls when activated

hematopoietic system
• size of spleen increases with age with mean cellularity being over 2-fold higher than controls by 5 months of age
• the number of CD45R+ B cells is increased in in the enlarged lymph node organs
• the number of CD4-positive T cells increases by 1.3 to 2.7 fold in in the enlarged lymph node organs
• the number of CD8-positive T cells increases by 1.3 to 2.7 fold in the enlarged lymph node organs
• B cells stimulated with anti-CD40 produce more immunoglobulins than controls
• addition of IL-6 to stimulation enhances even more the production of immunoglobulins
• production of antigen-specific IgG2a is increased in these mice after immunization with T cell dependent antigen
• production of antigen-specific IgG2b is increased in these mice after immunization with T cell dependent antigen

nervous system
• the abnormal action potential of cardiomycoytes at 80% repolarization is not prolonged to the extent wild-type cardiomyocytes are when LIF is administered
• L-type Ca2+ current intensities in cardiomyocytes are not influenced by IL-6 or LIF incubation as wild-type cardiomyocytes are

cardiovascular system
• L-type Ca2+ current intensities in cardiomyocytes are not influenced by IL-6 or LIF incubation as wild-type cardiomyocytes are
• transient increases of intracellular calcium in cardiomyocytes are not influenced by IL-6 or LIF neither




Genotype
MGI:3843819
cx4
Allelic
Composition
Il6sttm1Thir/Il6sttm1Thir
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
Genetic
Background
involves: 129 * C57BL/6 * DBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6sttm1Thir mutation (1 available); any Il6st mutation (80 available)
Tg(TcraH-Y,TcrbH-Y)71Vbo mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• the number of CD8lo single-positive thymocytes bearing transgenic TCR are several fold higher than in controls indicating a defect in negative selection

hematopoietic system
• the number of CD8lo single-positive thymocytes bearing transgenic TCR are several fold higher than in controls indicating a defect in negative selection




Genotype
MGI:3843820
cx5
Allelic
Composition
Il6sttm1Thir/Il6sttm1Thir
Rag2tm1Fwa/Rag2tm1Fwa
Genetic
Background
involves: 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6sttm1Thir mutation (1 available); any Il6st mutation (80 available)
Rag2tm1Fwa mutation (45 available); any Rag2 mutation (119 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• the arthritis observed in Il6sttm1Thir homozygotes is not observed in these mice demonstrating functional lymphocytes are essential for disease





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory